Novel therapies for epilepsy in the pipeline. (2019)
Attributed to:
Gene therapy for refractory epilepsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.yebeh.2019.04.042
PubMed Identifier: 31284159
Publication URI: http://europepmc.org/abstract/MED/31284159
Type: Journal Article/Review
Volume: 97
Parent Publication: Epilepsy & behavior : E&B
ISSN: 1525-5050